Ovid Therapeutics
Price & Volume
Stats
See more52W Range | $0.24-$2.01 |
Market Cap | $123.7M |
Shares Short | 680,035 |
Financials
See moreRevenue (12 Mos) | $6.6M |
Revenue Growth (YoY) | 3,611.2% |
Gross Profit (12 Mos) | $6.6M |
Diluted EPS | -$0.54 |
News
See moreYahoo Finance • 2 days ago
Ovid spikes as Wedbush moves to Outperform on lead asset
Yahoo Finance • 8 days ago
Ovid rises after positive results from epilepsy study
Yahoo Finance • 10 days ago
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
Yahoo Finance • 15 days ago
Mixed Catalysts Drive After-Hours Moves In MRM, LEXX, SHOT, AQST, And OVID
About
CEO | Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. |
Address | 441 Ninth Avenue, New York, NY, United States, 10001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
